The intravascular catheters market is set to reach US$ 8,051.7 Mn by 2027 from US$ 4,034.7 Mn in 2018 showcasing balanced growth at a compounded annual growth rate (CAGR) of 8.0% during the forecast period from 2019 to 2027. The major drivers associated with the intravascular catheters market growth are significant rise in inpatient surgical procedures in hospitals for treatment of chronic illness and increasing demand for catheters in minimal invasive surgical procedures conducted in catheterization labs & ambulatory care centers.

The global HbA1c testing devices market is growing at a significant rate, expected to grow at a CAGR of 10.1%. Worldwide, the increasing incidences of diabetes and other lifestyle diseases will drive the market growth globally. As per the data by International Diabetes Federation, in 2019, more than 430 Mn people were reported to have diabetes, i.e. 9.3% of the world’s population. The rate is going to increase by 10.3% by 2030 and 10.9% by 2045, i.e. around 700 Mn.

The global GERD devices market is growing proficiently, expected to grow at a CAGR of 3.7%. GERD is a common disease with the highest prevalence in North America. A recent study from the U.S. revealed that prevalence of gastroesophageal reflux disease ranged from 18% to 27% in North America, 8% to 25% in Europe, 8% to 30% in the Middle East, 2% to 7% in Asia, and around 22% in Latin America.

The gastric electrical stimulators market is set to reach from US$ 108.3 Mn in 2018 to US$ 192.2 Mn by 2027 at a compound annual growth rate (CAGR) of 6.7% during the forecast period from 2019 to 2027. Gastric electrical stimulators are small devices which are operated by battery to promote neurostimulation in the abdominal region via lead electrodes for treatment of gastroparesis. They are also used in treating obesity by modulating the appetite and satiety in obese people resulting in weight loss. Existence of few players in the market provides a potential platform for other medical device companies to enter in to the gastric electrical stimulators market.

The global enteral syringe market is increasing proficiently, expected to grow at a CAGR of 5.3%. Globally, the rising commonness of chronic illness and numerous lifestyle disorders will drive the overall growth of the market. Enteral syringes deliver nutritional therapy or medications to different age groups including pediatrics, and adult patients. Enteral syringes are available in different sizes ranging from 1ml to 60 ml and are generally used for patients in hospitals/clinics, and home care.

The global disposable hypodermic syringes market is witnessing a steady growth, expected to grow at a CAGR of 6.2%. Worldwide, the increasing prevalence of diabetes, multiple sclerosis, and numerous lifestyle diseases will drive the overall market growth. Globally, rising number of surgeries, increased growth of biologics, advancement in hypodermic syringes with fixed dosage, low cost medical devices, and decreased microbial contamination risk along with reduced medication errors are key factors driving the overall growth of the disposable hypodermic syringes market.

The deflectable catheters market is set to reach from US$ 1,564.9 Mn in 2018 to US$ 2,246.6 Mn by 2027 at a compound annual growth rate (CAGR) of 4.1% during the forecast period from 2019 to 2027. Rising public health awareness and technological advancement in the development of deflectable catheters for its application as diagnostic and medical interventional device determines the deflectable catheters market growth during the forecast period.

The global collagen meniscus implant (CMI) market is witnessing a steady growth, expected to grow at a CAGR of 5.3%. Globally, the increasing commonness of arthritis, sports injury, and numerous bone disorders will drive the overall market growth. Collagen meniscus implants are completely absorbable implant and biological, made from purified collagen. It is specifically designed to faciliate the growth of new tissue. For e.g. Stryker Collagen Meniscus Implant (CMI®).

The global cardiac biomarker diagnostic kits market is growing competently, expected to grow at a CAGR of 5.3%. Globally, the rising prevalence of chronic diseases, cardiac disorders along with numerous lifestyle diseases will drive the market growth globally. Major factors such as growing elderly population, increasing hospital admissions for cardiovascular diseases and enhanced product penetration in the developing nations are driving the global market. Present clinical trials for identification of innovative cardiac biomarkers, public and private funding for improved R&D is also increasing the market growth on a global scale.

Globally, the brain machine interfaces market is expected to grow with a CAGR of more than 10.1% during the forecast period from 2019 to 2027, starting from US$ 1.05 Bn in 2018. Factors attributed to the growth of brain machine interfaces market includes increasing penetration of advanced technologies in the field of neuroscience, growing incidences and prevalence of brain disorders affecting the movements of body, increasing government funding for research and development of brain machine interface technologies, miniaturization of components, and increasing number of gaming industries implementing brain machine interface technologies.

The bone sonometer market is set to reach from US$ 890.2 Mn in 2018 to US$ 1,428.9 Mn by 2027 expanding at a compound annual growth rate (CAGR) of 5.5% during the forecast period from 2019 to 2027. As per the latest research findings brought forward by the International Osteoporosis Foundation (IOF) in 2017, approximately 8.9 million fractures associated with osteoporosis were recorded throughout the globe. Looming threat of malnutrition and significant rise in geriatric population will propel the bone sonometer market growth in the near future.

The global bone cement market is growing proficiently, expected to grow at a CAGR of 6.3%. Bone cement is essentially used for widely used for implant fixation in various orthopaedic and trauma surgery. Globally, the growing prevalence for osteoporosis, increasing implantation procedures, spinal, hip and knee surgical procedures (mainly arthroplasty) among the geriatric population will drive the overall market growth.

The global blood dialyzer market is increasing proficiently, expected to grow at a CAGR of 7.0%. Worldwide, the increasing prevalence of chronic or acute kidney failure and other kidney-related disorders along with hemodialysis (procedure for removal of waste from the blood) procedures will drive the overall growth of the market. Growing awareness about new synthetic membrane technology to overcome the limitations by traditional procedures along with the launch of advanced products with compatible solutions will increase the overall demand in the near future.

The global bioresorbable vascular scaffold market is growing proficiently, expected to grow at a CAGR of 10.3%. Worldwide, the increasing prevalence of coronary heart-related disorders and other cardiovascular disorders will drive the growth of the market. Increasing awareness about new bioabsorbable technology to overcome the limitations by permanent metallic endoprosthesis along with the launch of advanced cardiac stents with integrated solutions will boost the overall demand in the developed nations.

The global audiological devices market accounted for US$ 9,934.9 Mn in 2018 and is anticipated to grow to US$ 16,007.8 Mn growing at a CAGR of 5.5% throughout the forecast period from 2019 to 2027. In 2018, in terms of volume market register sales of 15.80 Mn units and anticipated to reach 25.95 Mn Units expanding at a CAGR of 5.7%.

The anaplastic lymphoma kinase (ALK) inhibitors market is set to reach from US$ 1,496.4 Mn in 2018 to 8,329.1 Mn by 2027 keen to demonstrate exuberating growth at a compounded annual growth rate (CAGR) of 21.2% during the forecast period from 2019 to 2027. Lung cancer is the second most occurring type of cancer in both men and women population worldwide. Increased consumption of tobacco, unhealthy lifestyle and stress are the major risk factor responsible for the occurrence of lung cancer. A strong drug pipeline of second and third-generation ALK inhibitors being currently studied in various stages of clinical trials are being developed specifically for the treatment of non small cell lung cancer (NSCLC).

The amniocentesis needles market is set to reach from US$ 156.4 Mn in 2018 to US$ 205.8 Mn by 2027 at a compound annual growth rate (CAGR) of 3.1% during the forecast period from 2019 to 2027. Amniocentesis is frequently performed in prenatal diagnosis to identify any chromosomal abnormalities, neural tube defect and fetal infections during pregnancy. Rising public health awareness and implementation of effective health guidelines pertaining to obstetrics and gynecology drive the amniocentesis needles market growth.

The global AI-based medical diagnostic tools market is increasing proficiently, expected to grow at a CAGR of 25.6%. Internationally, increasing prevalence of lifestyle diseases along with huge patient population has suggestively enhanced the growth of artificial intelligence in the healthcare industry. New FDA approvals of AI systems along with enhanced & integrated algorithms, and promising pipeline devices in the medical diagnostics industry are key factors driving the overall growth of AI-based medical diagnostic tools market globally.

Global lab automation market is expected to rise with a CAGR of 5% during the forecast period 2019-2026. Lab automation offers several advantages such as reduction in lab process cycle time, high efficiency, enhance the quality of experimental data etc. Lab automation has wide applications in automated analytical and  clinical testing, high-throughput screening, large scale biorepositories, combinatorial chemistry etc.

The ultrasound image analysis software market is estimated to grow with a CAGR of around 9.1% during the forecast period 2019-2026. Rising prevalence of chronic diseases, technological advancements are some of the major factors that boost growth in the global market. High prevalence of chronic diseases such as cancer and diabetes is one of the major factors that contributes towards the growth of global market. According to American Society of Clinical Oncology (ASCO), the global cancer burden is expected to account for 13 million deaths per year by 2030. Similarly, according to International Diabetes Federation (IDF), 425 million individuals across the world have diabetes and this number is expected to rise to 629 million by 2045.